Proinflammatory and Antiinflammatory Peptides
Herausgeber: Said, Sami I
Proinflammatory and Antiinflammatory Peptides
Herausgeber: Said, Sami I
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
"Analyzes the role of peptides in promoting or suppressing inflammation. Thoroughly examines the therapeutic potential of key peptides, analogs, agonists, and antagonists that influence cell injury and repair."
Andere Kunden interessierten sich auch für
- Pharmaceutical Inhalation Aerosol Technology, Third Edition72,99 €
- Handbook of Cell-Penetrating Peptides92,99 €
- Bioactive Peptides88,99 €
- Eve HannaGene and Cell Therapies154,99 €
- Krish MoorthyFundamentals of Biochemical Calculations68,99 €
- Jun-Ping XuCancer Inhibitors from Chinese Natural Medicines69,99 €
- Lawrence E WilliamsRadiopharmaceuticals69,99 €
-
-
-
"Analyzes the role of peptides in promoting or suppressing inflammation. Thoroughly examines the therapeutic potential of key peptides, analogs, agonists, and antagonists that influence cell injury and repair."
Produktdetails
- Produktdetails
- Verlag: Taylor and Francis
- Seitenzahl: 760
- Erscheinungstermin: 23. September 2019
- Englisch
- Abmessung: 229mm x 152mm x 33mm
- Gewicht: 953g
- ISBN-13: 9780367400675
- ISBN-10: 0367400677
- Artikelnr.: 57815192
- Verlag: Taylor and Francis
- Seitenzahl: 760
- Erscheinungstermin: 23. September 2019
- Englisch
- Abmessung: 229mm x 152mm x 33mm
- Gewicht: 953g
- ISBN-13: 9780367400675
- ISBN-10: 0367400677
- Artikelnr.: 57815192
Sami I. Said
Part 1 Cell injury and inflammation: inflammation, cell injury and
apoptosis; proinflammatory and antiinflammatory response cytokines in the
inflammatory response. Part 1 Proinflammatory peptides: proinflammatory
peptides in sensory nerves of the airways; sensory neuropeptides and
bronchial hyperresponsiveness; the tachykinin family of peptides and their
receptors; endothelins in inflammation; endothelins in the lung;
proinflammatory peptides in relation to other inflammatory mediators;
cellular regulation of kinin receptors - potential roles in inflammation.
Part 3 Antiinflammatory peptides: modulation of inflammatory effects of
cytokines by the neuropeptide -MSH; regulation of VIP gene expression;
neuroregulation of pulmonary immune responses by VIP and substance P; role
of vasoactive intestinal peptide in myocardial ischaemia - reperfusion
injury; antiinflammatory actions of VIP in the lungs and airways; VIP
regulation of neuronal proliferation and differentiation; implications for
neuronal repair; neurotrophic action of VIP - from CNS ontogeny to
therapeutic strategy. Part 4 Modulation of peptide action - therapeutic
applications: long-acting VIP analogs; catalytic anti-VIP antibodies and
their relevance to the airways; enzymatic degradation of bradykinin;
enzymatic modulation of the tachykinins and VIP in the lung; therapeutic
effects and immunomodulatory activities of natriuretic peptides.
apoptosis; proinflammatory and antiinflammatory response cytokines in the
inflammatory response. Part 1 Proinflammatory peptides: proinflammatory
peptides in sensory nerves of the airways; sensory neuropeptides and
bronchial hyperresponsiveness; the tachykinin family of peptides and their
receptors; endothelins in inflammation; endothelins in the lung;
proinflammatory peptides in relation to other inflammatory mediators;
cellular regulation of kinin receptors - potential roles in inflammation.
Part 3 Antiinflammatory peptides: modulation of inflammatory effects of
cytokines by the neuropeptide -MSH; regulation of VIP gene expression;
neuroregulation of pulmonary immune responses by VIP and substance P; role
of vasoactive intestinal peptide in myocardial ischaemia - reperfusion
injury; antiinflammatory actions of VIP in the lungs and airways; VIP
regulation of neuronal proliferation and differentiation; implications for
neuronal repair; neurotrophic action of VIP - from CNS ontogeny to
therapeutic strategy. Part 4 Modulation of peptide action - therapeutic
applications: long-acting VIP analogs; catalytic anti-VIP antibodies and
their relevance to the airways; enzymatic degradation of bradykinin;
enzymatic modulation of the tachykinins and VIP in the lung; therapeutic
effects and immunomodulatory activities of natriuretic peptides.
Part 1 Cell injury and inflammation: inflammation, cell injury and
apoptosis; proinflammatory and antiinflammatory response cytokines in the
inflammatory response. Part 1 Proinflammatory peptides: proinflammatory
peptides in sensory nerves of the airways; sensory neuropeptides and
bronchial hyperresponsiveness; the tachykinin family of peptides and their
receptors; endothelins in inflammation; endothelins in the lung;
proinflammatory peptides in relation to other inflammatory mediators;
cellular regulation of kinin receptors - potential roles in inflammation.
Part 3 Antiinflammatory peptides: modulation of inflammatory effects of
cytokines by the neuropeptide -MSH; regulation of VIP gene expression;
neuroregulation of pulmonary immune responses by VIP and substance P; role
of vasoactive intestinal peptide in myocardial ischaemia - reperfusion
injury; antiinflammatory actions of VIP in the lungs and airways; VIP
regulation of neuronal proliferation and differentiation; implications for
neuronal repair; neurotrophic action of VIP - from CNS ontogeny to
therapeutic strategy. Part 4 Modulation of peptide action - therapeutic
applications: long-acting VIP analogs; catalytic anti-VIP antibodies and
their relevance to the airways; enzymatic degradation of bradykinin;
enzymatic modulation of the tachykinins and VIP in the lung; therapeutic
effects and immunomodulatory activities of natriuretic peptides.
apoptosis; proinflammatory and antiinflammatory response cytokines in the
inflammatory response. Part 1 Proinflammatory peptides: proinflammatory
peptides in sensory nerves of the airways; sensory neuropeptides and
bronchial hyperresponsiveness; the tachykinin family of peptides and their
receptors; endothelins in inflammation; endothelins in the lung;
proinflammatory peptides in relation to other inflammatory mediators;
cellular regulation of kinin receptors - potential roles in inflammation.
Part 3 Antiinflammatory peptides: modulation of inflammatory effects of
cytokines by the neuropeptide -MSH; regulation of VIP gene expression;
neuroregulation of pulmonary immune responses by VIP and substance P; role
of vasoactive intestinal peptide in myocardial ischaemia - reperfusion
injury; antiinflammatory actions of VIP in the lungs and airways; VIP
regulation of neuronal proliferation and differentiation; implications for
neuronal repair; neurotrophic action of VIP - from CNS ontogeny to
therapeutic strategy. Part 4 Modulation of peptide action - therapeutic
applications: long-acting VIP analogs; catalytic anti-VIP antibodies and
their relevance to the airways; enzymatic degradation of bradykinin;
enzymatic modulation of the tachykinins and VIP in the lung; therapeutic
effects and immunomodulatory activities of natriuretic peptides.